This concept seemed substantiated by studies on mice with high levels of active CYP1A1 (due to a high affinity AHR), which were more susceptible to cancers and genotoxicity when the PAH was brought in direct contact with the corresponding organs, but not after oral, systemic application [31], [32]. This evidence concerns the gene CYP1A1 and cancer.